Angiomics


Public list: Pharma Startups (6570) Cancer Therapeutics (1180)

Angiomics is a research and development company dedicated to improving vascular health. Using next-generation assays, we test efficacy of materials and agents for use as therapies affecting blood vessel growth. We provide support to Industrial, Medical and Academic research customers. Seed stage cancer therapy spinout from Duke University. Research focused on inhibiting new blood vessel growth. Assets acquired by Protein Design Labs in 2004.

Angiomics is a research and development company dedicated to improving vascular health. Using next-generation assays, we test efficacy of materials and agents for use as therapies affecting blood vessel growth. We provide support to Industrial, Medic...Show all

Company (Acquired)

Phone:

Fax:

Indianapolis, Indiana, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Angiomics $0M Aug 2, 2004
Axela Biosensors $5.8M Jan 7, 2011
See all 14 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Angiomics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 14 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)